Mechanism of action
The drug's action is based on a myotropic antispasmodic effect. Vinpocetine inhibits the enzyme phosphodiesterase, leading to the accumulation of cAMP in smooth muscle cells of the vascular wall. This causes their relaxation and dilation of the vascular lumen, predominantly in the cerebral circulation.
Pharmacological effects
The drug has a complex effect on cerebral hemodynamics and metabolism:
- Vascular effect: selective dilation of cerebral blood vessels without the "steal" phenomenon (blood flow increases specifically in ischemic areas).
- Rheological effect: reduction of blood viscosity, decrease in platelet aggregation, and increase in erythrocyte deformability.
- Neuroprotection: increased neuronal resistance to hypoxia, improved glucose uptake and metabolism, shifting metabolism to the aerobic pathway.
Indications
Vinpocetine is used for chronic cerebral circulation insufficiency, during the rehabilitation period after a stroke, and for neuropsychiatric disorders associated with cerebrovascular insufficiency. It is also used in ophthalmology (vascular eye diseases) and otorhinolaryngology (hearing loss of vascular or toxic origin).
Side effects
Common side effects include decreased blood pressure, nausea, and dizziness. Rapid intravenous administration may cause cardiac arrhythmias (tachycardia, extrasystoles) and slowing of intraventricular conduction.
Prescription details
The drug is taken orally in long courses (1–2 tablets of 0.005 g 3 times daily after meals). If necessary, it is administered intravenously via drip infusion: 4 ml of 0.5% concentrate (20 mg) is diluted in 500 ml of 0.9% NaCl solution. The infusion rate should be 80 drops per minute.
Briefly: answers to topical questions
What are the absolute contraindications to prescribing vinpocetine?
The provided materials do not list absolute contraindications to prescribing vinpocetine. It is noted that steno-occlusive lesions of extra- and intracranial vessels require special caution due to the risk of the steal syndrome. The criteria for prescribing in the early and late recovery periods of ischemic stroke or TIA are provided: absence of hemodynamically significant steno-occlusive lesions of precerebral and cerebral arteries, low risk of hemorrhagic complications, and no need for heparin and anticoagulant therapy.
Vinpocetine — "Vin" (periwinkle) + "Po" (increases) + "Cet" (cAMP) + "In" (inhibits PDE).
Class and exam questions
Why doesn't vinpocetine cause the "steal" phenomenon?
The drug does not affect blood flow in intact (healthy) vessels, acting selectively on vessels in ischemic areas of the brain.
What biochemical process underlies the myotropic action of vinpocetine?
Inhibition of phosphodiesterase, which leads to cAMP accumulation and vascular smooth muscle relaxation.
What complications can occur with intravenous administration that is too rapid?
Tachycardia, extrasystoles, and slowing of intraventricular conduction are possible.
What else to study on this topic
- Comparative profile of vinpocetine and nicergoline.
- Mechanisms of neuroprotection in cerebral ischemia: the role of NMDA receptor antagonists.
- Classification of vasodilators that improve cerebral blood flow.
- The role of calcium channel blockers (nimodipine) in the treatment of subarachnoid hemorrhages.
- Effect of ergot alkaloid derivatives on peripheral circulation.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Vinpocetine" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.